Literature DB >> 9740813

Substance use, abuse and dependence in Germany. A review of selected epidemiological data.

A Perkonigg1, R Lieb, H U Wittchen.   

Abstract

To provide background information about previous findings about the prevalence of use, abuse and dependence of various substances (nicotine, alcohol, prescription and illicit drugs) findings of available epidemiological studies in Germany from the 1980s and 1990s are summarized and critically evaluated. Focusing on findings of substance use surveys in adolescents and young adults the review indicates: (a) a considerable number of large scale questionnaire surveys in general population samples documenting the frequency of use and patterns of use of most substances; (b) indications of increasing rates of drug use particularly in East Germany; (c) high rates of illicit drug use, mainly of cannabinoids, but also stimulants and hallucinogens, among young age groups. No data are available from substance use surveys or from clinical epidemiological studies allowing the determination of how frequent substance abuse and substance dependence diagnoses are in the general population or in adolescents and young adults. Priorities for future research to ameliorate this unsatisfactory situation are outlined with emphasis on research in adolescents and young adults.

Entities:  

Mesh:

Year:  1998        PMID: 9740813     DOI: 10.1159/000018920

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  2 in total

1.  Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent inpatient psychiatric population.

Authors:  Oliver Niethammer; Reiner Frank
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12-14       Impact factor: 4.785

2.  Aims, design and methods of the Smoking and Nicotine Dependence Awareness and Screening (SNICAS) study.

Authors:  Stephan Muehlig; Eva Hoch; Michael Hoefler; David Pittrow; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.